Global Pompe Disease Treatment Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Pompe Disease Treatment market report explains the definition, types, applications, major countries, and major players of the Pompe Disease Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Amicus Therapeutics

    • Sanofi Genzyme

    • Valerion Therapeutics

    • Sangamo BioSciences

    • EpiVax

    • Oxyrane

    • Audentes Therapeutics

    By Type:

    • Infantile-Onset Pompe Disease

    • Adult-Onset Pompe Disease

    By End-User:

    • Hospital

    • Medical Center

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Pompe Disease Treatment Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Pompe Disease Treatment Outlook to 2028- Original Forecasts

    • 2.2 Pompe Disease Treatment Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Pompe Disease Treatment Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Pompe Disease Treatment Market- Recent Developments

    • 6.1 Pompe Disease Treatment Market News and Developments

    • 6.2 Pompe Disease Treatment Market Deals Landscape

    7 Pompe Disease Treatment Raw Materials and Cost Structure Analysis

    • 7.1 Pompe Disease Treatment Key Raw Materials

    • 7.2 Pompe Disease Treatment Price Trend of Key Raw Materials

    • 7.3 Pompe Disease Treatment Key Suppliers of Raw Materials

    • 7.4 Pompe Disease Treatment Market Concentration Rate of Raw Materials

    • 7.5 Pompe Disease Treatment Cost Structure Analysis

      • 7.5.1 Pompe Disease Treatment Raw Materials Analysis

      • 7.5.2 Pompe Disease Treatment Labor Cost Analysis

      • 7.5.3 Pompe Disease Treatment Manufacturing Expenses Analysis

    8 Global Pompe Disease Treatment Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Pompe Disease Treatment Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Pompe Disease Treatment Export by Region (Top 10 Countries) (2017-2028)

    9 Global Pompe Disease Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Pompe Disease Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Infantile-Onset Pompe Disease Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Adult-Onset Pompe Disease Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pompe Disease Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Medical Center Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Pompe Disease Treatment Market Analysis and Outlook till 2022

    • 10.1 Global Pompe Disease Treatment Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Pompe Disease Treatment Consumption (2017-2022)

      • 10.2.2 Canada Pompe Disease Treatment Consumption (2017-2022)

      • 10.2.3 Mexico Pompe Disease Treatment Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Pompe Disease Treatment Consumption (2017-2022)

      • 10.3.2 UK Pompe Disease Treatment Consumption (2017-2022)

      • 10.3.3 Spain Pompe Disease Treatment Consumption (2017-2022)

      • 10.3.4 Belgium Pompe Disease Treatment Consumption (2017-2022)

      • 10.3.5 France Pompe Disease Treatment Consumption (2017-2022)

      • 10.3.6 Italy Pompe Disease Treatment Consumption (2017-2022)

      • 10.3.7 Denmark Pompe Disease Treatment Consumption (2017-2022)

      • 10.3.8 Finland Pompe Disease Treatment Consumption (2017-2022)

      • 10.3.9 Norway Pompe Disease Treatment Consumption (2017-2022)

      • 10.3.10 Sweden Pompe Disease Treatment Consumption (2017-2022)

      • 10.3.11 Poland Pompe Disease Treatment Consumption (2017-2022)

      • 10.3.12 Russia Pompe Disease Treatment Consumption (2017-2022)

      • 10.3.13 Turkey Pompe Disease Treatment Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Pompe Disease Treatment Consumption (2017-2022)

      • 10.4.2 Japan Pompe Disease Treatment Consumption (2017-2022)

      • 10.4.3 India Pompe Disease Treatment Consumption (2017-2022)

      • 10.4.4 South Korea Pompe Disease Treatment Consumption (2017-2022)

      • 10.4.5 Pakistan Pompe Disease Treatment Consumption (2017-2022)

      • 10.4.6 Bangladesh Pompe Disease Treatment Consumption (2017-2022)

      • 10.4.7 Indonesia Pompe Disease Treatment Consumption (2017-2022)

      • 10.4.8 Thailand Pompe Disease Treatment Consumption (2017-2022)

      • 10.4.9 Singapore Pompe Disease Treatment Consumption (2017-2022)

      • 10.4.10 Malaysia Pompe Disease Treatment Consumption (2017-2022)

      • 10.4.11 Philippines Pompe Disease Treatment Consumption (2017-2022)

      • 10.4.12 Vietnam Pompe Disease Treatment Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Pompe Disease Treatment Consumption (2017-2022)

      • 10.5.2 Colombia Pompe Disease Treatment Consumption (2017-2022)

      • 10.5.3 Chile Pompe Disease Treatment Consumption (2017-2022)

      • 10.5.4 Argentina Pompe Disease Treatment Consumption (2017-2022)

      • 10.5.5 Venezuela Pompe Disease Treatment Consumption (2017-2022)

      • 10.5.6 Peru Pompe Disease Treatment Consumption (2017-2022)

      • 10.5.7 Puerto Rico Pompe Disease Treatment Consumption (2017-2022)

      • 10.5.8 Ecuador Pompe Disease Treatment Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Pompe Disease Treatment Consumption (2017-2022)

      • 10.6.2 Kuwait Pompe Disease Treatment Consumption (2017-2022)

      • 10.6.3 Oman Pompe Disease Treatment Consumption (2017-2022)

      • 10.6.4 Qatar Pompe Disease Treatment Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Pompe Disease Treatment Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Pompe Disease Treatment Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Pompe Disease Treatment Consumption (2017-2022)

      • 10.7.2 South Africa Pompe Disease Treatment Consumption (2017-2022)

      • 10.7.3 Egypt Pompe Disease Treatment Consumption (2017-2022)

      • 10.7.4 Algeria Pompe Disease Treatment Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Pompe Disease Treatment Consumption (2017-2022)

      • 10.8.2 New Zealand Pompe Disease Treatment Consumption (2017-2022)

    11 Global Pompe Disease Treatment Competitive Analysis

    • 11.1 Amicus Therapeutics

      • 11.1.1 Amicus Therapeutics Company Details

      • 11.1.2 Amicus Therapeutics Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Amicus Therapeutics Pompe Disease Treatment Main Business and Markets Served

      • 11.1.4 Amicus Therapeutics Pompe Disease Treatment Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sanofi Genzyme

      • 11.2.1 Sanofi Genzyme Company Details

      • 11.2.2 Sanofi Genzyme Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sanofi Genzyme Pompe Disease Treatment Main Business and Markets Served

      • 11.2.4 Sanofi Genzyme Pompe Disease Treatment Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Valerion Therapeutics

      • 11.3.1 Valerion Therapeutics Company Details

      • 11.3.2 Valerion Therapeutics Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Valerion Therapeutics Pompe Disease Treatment Main Business and Markets Served

      • 11.3.4 Valerion Therapeutics Pompe Disease Treatment Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Sangamo BioSciences

      • 11.4.1 Sangamo BioSciences Company Details

      • 11.4.2 Sangamo BioSciences Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Sangamo BioSciences Pompe Disease Treatment Main Business and Markets Served

      • 11.4.4 Sangamo BioSciences Pompe Disease Treatment Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 EpiVax

      • 11.5.1 EpiVax Company Details

      • 11.5.2 EpiVax Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 EpiVax Pompe Disease Treatment Main Business and Markets Served

      • 11.5.4 EpiVax Pompe Disease Treatment Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Oxyrane

      • 11.6.1 Oxyrane Company Details

      • 11.6.2 Oxyrane Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Oxyrane Pompe Disease Treatment Main Business and Markets Served

      • 11.6.4 Oxyrane Pompe Disease Treatment Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Audentes Therapeutics

      • 11.7.1 Audentes Therapeutics Company Details

      • 11.7.2 Audentes Therapeutics Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Audentes Therapeutics Pompe Disease Treatment Main Business and Markets Served

      • 11.7.4 Audentes Therapeutics Pompe Disease Treatment Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Pompe Disease Treatment Market Outlook by Types and Applications to 2028

    • 12.1 Global Pompe Disease Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Infantile-Onset Pompe Disease Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Adult-Onset Pompe Disease Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Pompe Disease Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Medical Center Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Pompe Disease Treatment Market Analysis and Outlook to 2028

    • 13.1 Global Pompe Disease Treatment Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.2.2 Canada Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Pompe Disease Treatment Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.2 UK Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.3 Spain Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.5 France Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.6 Italy Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.8 Finland Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.9 Norway Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.11 Poland Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.12 Russia Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Pompe Disease Treatment Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.2 Japan Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.3 India Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Pompe Disease Treatment Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.3 Chile Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.6 Peru Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Pompe Disease Treatment Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.6.3 Oman Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Pompe Disease Treatment Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Pompe Disease Treatment Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Pompe Disease Treatment Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Pompe Disease Treatment Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Pompe Disease Treatment

    • Figure of Pompe Disease Treatment Picture

    • Table Global Pompe Disease Treatment Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Pompe Disease Treatment Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Infantile-Onset Pompe Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Adult-Onset Pompe Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Center Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Pompe Disease Treatment Consumption by Country (2017-2022)

    • Table North America Pompe Disease Treatment Consumption by Country (2017-2022)

    • Figure United States Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Canada Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Mexico Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Pompe Disease Treatment Consumption by Country (2017-2022)

    • Figure Germany Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure UK Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Spain Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Belgium Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure France Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Italy Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Denmark Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Finland Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Norway Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Sweden Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Poland Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Russia Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Turkey Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table APAC Pompe Disease Treatment Consumption by Country (2017-2022)

    • Figure China Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Thailand Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Singapore Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Philippines Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table South America Pompe Disease Treatment Consumption by Country (2017-2022)

    • Figure Brazil Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Colombia Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Chile Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Argentina Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Peru Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table GCC Pompe Disease Treatment Consumption by Country (2017-2022)

    • Figure Bahrain Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Oman Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Qatar Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table Africa Pompe Disease Treatment Consumption by Country (2017-2022)

    • Figure Nigeria Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Africa Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Egypt Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure Algeria Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table Oceania Pompe Disease Treatment Consumption by Country (2017-2022)

    • Figure Australia Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Pompe Disease Treatment Consumption and Growth Rate (2017-2022)

    • Table Amicus Therapeutics Company Details

    • Table Amicus Therapeutics Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amicus Therapeutics Pompe Disease Treatment Main Business and Markets Served

    • Table Amicus Therapeutics Pompe Disease Treatment Product Portfolio

    • Table Sanofi Genzyme Company Details

    • Table Sanofi Genzyme Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Genzyme Pompe Disease Treatment Main Business and Markets Served

    • Table Sanofi Genzyme Pompe Disease Treatment Product Portfolio

    • Table Valerion Therapeutics Company Details

    • Table Valerion Therapeutics Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valerion Therapeutics Pompe Disease Treatment Main Business and Markets Served

    • Table Valerion Therapeutics Pompe Disease Treatment Product Portfolio

    • Table Sangamo BioSciences Company Details

    • Table Sangamo BioSciences Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sangamo BioSciences Pompe Disease Treatment Main Business and Markets Served

    • Table Sangamo BioSciences Pompe Disease Treatment Product Portfolio

    • Table EpiVax Company Details

    • Table EpiVax Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table EpiVax Pompe Disease Treatment Main Business and Markets Served

    • Table EpiVax Pompe Disease Treatment Product Portfolio

    • Table Oxyrane Company Details

    • Table Oxyrane Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Oxyrane Pompe Disease Treatment Main Business and Markets Served

    • Table Oxyrane Pompe Disease Treatment Product Portfolio

    • Table Audentes Therapeutics Company Details

    • Table Audentes Therapeutics Pompe Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Audentes Therapeutics Pompe Disease Treatment Main Business and Markets Served

    • Table Audentes Therapeutics Pompe Disease Treatment Product Portfolio

    • Figure Global Infantile-Onset Pompe Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult-Onset Pompe Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Center Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pompe Disease Treatment Consumption Forecast by Country (2022-2028)

    • Table North America Pompe Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pompe Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure Germany Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Pompe Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure China Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Pompe Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure Brazil Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Pompe Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Pompe Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Pompe Disease Treatment Consumption Forecast by Country (2022-2028)

    • Figure Australia Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Pompe Disease Treatment Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.